Latest Clinical and Quality-of-Life Data for TransCon™

Latest Clinical and Quality-of-Life Data for TransCon™ PTH (Palopegteriparatide)-Treated Adults with Chronic Hypoparathyroidism to Be Presented at ECE 2024

Latest Clinical and Quality-of-Life Data for TransCon™ PTH (Palopegteriparatide)-Treated Adults with Chronic Hypoparathyroidism to Be Presented at ECE 2024

marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Stockholm , Sweden , United Kingdom , China , Denmark , Japan , United States , Evisen , Vastra Gotalands Lan , Copenhagen , Køavn , Great Britain , Melinda Baker , Aimee Shu , Tim Lee , Peter Schwarz , Ascendis Pharma , Andrea Palermo , Heide Siggelkow , Us Food Drug Administration , Patti Bank , European Congress , European Commission , Teijin Ltd , Clinical Development , Medicines Healthcare Products Regulatory Agency , Endocrine Medical Sciences , Globenewswire Inc , Exchange Commission , Senior Vice President , Endocrine Medical , Renal Function , Chronic Hypoparathyroidism , Year Results , Current Management , Year Renal , Reported Outcomes , Initial Data , Compassionate Use , European Economic Area , Healthcare Products Regulatory Agency , Drug Administration , New Drug Application , Ascendi Annual Report ,